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SUMMARY
The main objective was to compare the in-hospital case-fatality rate of leptospirosis between pediatric (< 19 years) and adult (≥
19 years) patients, taking into account gender, renal function, duration of symptoms and jaundice. Medical records of 1016 patients
were reviewed. Comparative analysis was restricted to 840 patients (100 pediatric, 740 adults) with recorded information on the
variables included in the analysis. Among these patients 81.7% were male and 91.5% were icteric. The case-fatality rate of leptospirosis
was 14.4%. The odds of death adjusted for gender, jaundice, duration of symptoms, serum urea and serum creatinine were almost four
times higher for the adult than for the pediatric group (odds ratio (OR) = 3.94; 95% confidence interval = 1.19-13.03, p = 0.029).
Among adults, increased age was also significantly and independently associated with increased risk of death (p < 0.01). Older
patients were also more often treated by dialysis. In conclusion, the data suggest that the in-hospital case fatality rate of leptospirosis
is higher for adults than for children and adolescents, even after taking into account the effects of several potential risk factors of
death. Among adults, older age was also strongly and independently associated with higher risk of death.
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 INTRODUCTION
In Salvador, capital of Bahia and several other urban cities in Brazil,
leptospirosis is endemic with outbreaks occurring in close relation to
raining periods and floods2,4,11,14,15. Among the hospitalized cases, there
is a predominance of males and patients with ages between 19 and 39
years. The risk of death in these patients with leptospirosis admitted to
hospitals in Salvador has ranged from 12% to 15%2,10,19, being higher
for jaundiced patients and those with renal failure. It has been argued
that the high in-hospital death risk of patients with leptospirosis is
partially due to the delay to initiate antibiotic therapy7,10. This delay to
start the treatment of leptospirosis may be related to the fact that patients
with leptospirosis, both children and adults, are often misdiagnosed as
having other infectious diseases, particularly viral diseases7,17.
The existing data also suggest that the case-fatality rate of leptospirosis
is lower in children and adolescents than in adults and higher in the elderly
than in younger adults3,18. There is a lack of studies, however, developed
specifically to compare the prognosis of leptospirosis between patients of
different age groups. We studied a large sample of patients of different age
groups with the diagnosis of leptospirosis who were admitted to a reference
infectious disease hospital (Couto Maia Hospital), located in the city of
Salvador. The main objective was to compare mortality risk between
pediatric (< 19 years) and adult (≥ 19 years) patients of different age groups,
taking into account renal function, duration of symptoms and the presence
of jaundice at hospital admission. We also compared age groups regarding
treatment by dialysis and length of hospitalization.
METHODS
A retrospective study of 1016 patients diagnosed as leptospirosis
who were admitted to Couto Maia Hospital, Salvador, BA, Brazil,
between 1993 and 1997. Data were abstracted from medical charts, after
obtaining approval by the institutional review committee. The
comparative analysis was restricted to patients with recorded information
on death, age, duration of symptoms and initial levels of serum creatinine
and urea. The diagnosis of leptospirosis was based on clinical, laboratory
and epidemiological data according to the World Health Organization
(WHO) criteria6. All patients reached at least 26 points according to the
WHO criteria, a limit to define a case as having a high probability of
leptospirosis6.
The patients were divided into pediatric (< 19 years) and adult groups
(≥ 19 years). Patients from the adult group were further classified
according to the following age categories: 19-29, 30-39, 40-49, 50-59
and ≥ 60 years.
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The t-test for independent samples and one-way analysis of variance
were used to compare quantitative variables. The chi-square test, or the
Fisher’s exact test, was used to compare proportions. A non-parametric
test was used to compare medians13. This median test compares the groups
regarding the number of cases with values greater than the observed
median and less than or equal to the median. Multivariate logistic
regression was used to estimate the association between age and mortality
risk, adjusted for gender, duration of symptoms (> 4 days versus ≤ 4
days), presence of jaundice, and initial levels of serum creatinine and
serum urea. The statistical tests were two-tailed and p values below 0.05
were considered statistically significant.
RESULTS
Among 1016 cases, 840 (100 pediatric and 740 adult patients) had
complete information on the variables of main interest. Among the
pediatric patients, 34 were fourteen years old or younger and 66 were
between 15 and 18 years of age. Males corresponded to 81.7% of these
840 subjects and 91.5% were considered icteric at hospital admission.
An abrupt start of the clinical manifestations characterized by a
combination of fever, myalgia and headache was described for 98.6% of
the patients (828/840). The median duration of symptoms at admission
was six days. Among the 176 patients excluded from the analysis because
of missing values 97.2% were icteric and 78.4% were male.
Table 1 shows the patient characteristics at hospital admission by
age groups. The percent of males was significantly higher among pediatric
(93%) than among adult (80.1%) patients (p = 0.002). Among adults,
the percentage of males also decreased markedly as age increased, varying
from 88.7% for ages 19-29 years to 51.5% for ages ≥ 60 years. The
mean age was 34.1 ± 14.4 years for males and 44.7 ± 16.2 years for
females (p < 0.001). A significant lower percentage of jaundice was
observed among pediatric (80.0% vs 93.1% in adults) patients; however,
significant variation in the percentage of jaundiced patients was not
observed across the adult age groups. Duration of symptoms did not
vary significantly by age. In general, more than 75% of the patients had
more than four days of symptoms at hospital admission. Both serum
creatinine and urea levels increased significantly with age. More than
90% of the patients of the several age groups had serum creatinine
> 1.2mg/dl at hospital admission. By using different cut points for serum
creatinine, differences by age became statistically significant (p < 0.05)
for levels > 3.0 mg/dl. Similar percentages (p = 0.603) of patients with
serum creatinine > 1.0 mg/dl were observed for ages ≤ 14 (94.1%) and
ages 15-18 years (97.0%). The levels of bilirrubins, aspartate
aminotransferase and alanine aminotransferase did not vary significantly
by age. We have not observed a significant difference in the use of
penicillin during hospitalization between the pediatric (82%) and the
adult (78%) patients. Among adults, however, there was a significant,
non-linear, variation in the percentage of patients who received penicillin
by age groups with lower percentages being observed for ages 50 to 59
years (65%). The percentage of patients who received penicillin therapy
during the hospitalization period was significantly higher (p < 0.001) in
patients with duration of symptoms ≤ 4 days (90.2% versus 75%). The
variation in penicillin use across the adult age groups remained significant
after logistic regression adjustment for duration of symptoms.
In the total sample of 1016 cases, information on death or survival
was missing for seven patients transferred to other hospitals (four in the
age group ≥ 60 years, one in the group 30-39, one in the group 40-49
and one in the group 50-59 years). The case-fatality rate was 14.2% for
Table 1
Baseline characteristics and penicillin use during hospitalization by age groups
Pediatric Adult age groups All Adults
< 19 19-29 30-39 40-49 50-59 ≥ 60 ≥ 19 p among p (pediatric
n = 100 n = 213 n = 214 n = 145 n = 100 n = 68 n =740 adults vs adults)
% male 93.0 88.7 86.9 78.6 69.0 51.5 80.1 <0.001 0.002
% jaundiced 80.0 90.1 94.4 94.5 94.0 94.1 93.1 0.388 <0.001
% symptoms>4 days 75.0 73.7 74.8 74.5 83.0 77.9 75.8 0.439 0.859
Creatinine (mg/dl) 3.3±1.7 3.8±2.3 4.1±2.4 4.7±2.7 4.4±2.2 4.9±2.5 4.2±2.5 0.001 <0.001
% creatinine > 0.8 97.0 99.1 98.1 100.0 99.0 98.5 98.7 0.520* 0.133*
% creatinine > 1.0 96.0 94.8 96.3 98.6 97.0 97.1 96.5 0.429 0.773*
% creatinine > 1.2 91.0 91.5 92.5 94.5 96.0 94.1 93.2 0.594 0.410
% creatinine > 1.4 89.6 88.2 90.1 92.2 93.0 91.0 90.4 0.628 0.793
% creatinine > 2.5 60.0 64.3 66.4 74.5 75.0 76.5 69.5 0.079 0.056
% creatinine > 3.0 45.0 55.4 59.8 65.5 69.0 75.0 62.3 0.017 0.001
Urea (mg/dl) 121.8±80.3 128.2±85.6 144.7±90.3 159.1±98.0 196.7±119.7 201.6±115.2 155.0±100.6 <0.001 <0.001
Total bilirubin (mg/dl) 94.0±91.4 102.6±89.9 97.6±88.6 111.1±90.1 92.5±89.0 90.4±88.6 100.3±89.3 0.402 0.505
Direct bilirubin (mg/dl) 49.7±43.8 54.6±42.6 52.3±41.6 58.5±42.5 49.5±42.3 48.6±41.9 53.4±42.2 0.391 0.408
AST (units/l) 128.3±106.4 123.6±99.6 108.7±70.2 120.8±82.1 112.7±111.9 98.7±67.3 114.7±87.1 0.316 0.222
ALT (units/l) 76.3±60.2 89.86±91.8 72.2±60.7 84.2±84.4 76.7±100.7 60.7±50.4 78.9±80.0 0.129 0.795
% treated with penicillin 82.0 81.7 82.2 74.5 65.0 79.4 78.0 0.016 0.358
AST = Aspartate aminotransferase (SGOT); ALT = Alanine aminotransferase (SGPT); Cases with missing information: Bilirubin: one case for age 30-39; AST: 27,
61, 48, 42, 33 and 14 cases for ages < 19, 19-29, 30-39, 40-49, 50-59 and ≥60, respectively; ALT: 27, 62, 48, 42, 33 and 16 cases for ages <19, 19-29, 30-39, 40-
49, 50-59 and ≥60, respectively
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the 1009 patients with information on death or survival and 14.4 for the
group of 840 patients with complete information on the covariates
included in the logistic regression model. As shown in Table 2, the case-
fatality rate of leptospirosis increased steadily with age. It varied from
3.0% for the pediatric group to 36.8% for the group ≥ 60 years. The ages
of the three fatal pediatric cases were 13, 14 and 17 years. The deaths of
these three patients were attributed to renal failure. Among the 118 cases
of death in adult patients, 89 were attributed to renal failure, 12 to
gastrointestinal bleeding, 6 to septic shock, 4 to respiratory failure, 7 to
other causes and for one patient the data on cause of death was missing.
Almost 60% of the deaths occurred 48 hours after admission. The
percentage of these early deaths did not differ significantly by age (p =
0.755). Similarly, significant variation in early death was not observed
(p = 0.427) between patients with duration of symptoms ≤ 4 days (16
out of 30, 53.3%) and > 4 days (56 out of 91, 61.5%) The percentage of
patients who received dialysis varied significantly by age, being higher
for older groups (p < 0.001). This difference in dialysis treatment by age
remained significant (p = 0.04) in the analysis restricted to patients who
have not died during hospitalization. The percentages of patients with
hemorrhagic events were 20.0% in the pediatric group and 24.1% in the
adult group (p = 0.370). In the pediatric group the frequency of
hemorrhagic events was 4.6 times higher for ages 15-18 than for ages
≤ 14 years (p = 0.011). The median length of hospitalization was seven
days for each of the six age groups. On the other hand, among survivors
median length of hospitalization was significantly associated with age
(p = 0.001), being longer (median difference = 2 days) in patients ≥ 60
years than in patients ≤ 30 years.
Table 3 shows the odds ratios of the association between baseline
patient characteristics and in-hospital death, estimated by logistic
regression models. Age, creatinine and urea were significantly and
independently associated with death. The odds of death adjusted for
gender, jaundice, serum creatinine, serum urea and duration of symptoms,
increased 66% for each 10-year increase in age (adjusted OR = 1.66;
Table 3
Odds ratios of the association between baseline patient characteristic and in-hospital death
Unadjusted model Adjusted Model
Odds ratio (95 % CI) p value Odds ratio (95 % CI) p value
Age per 10 years 1.72(1.51-1.97) < 0.001 1.66(1.42-1.94) < 0.001
Adult group (vs pediatric group) 6.13(1.91-19.68) 0.001 3.94(1.19-13.03) 0.029
Male (vs female) 0.75(0.47-1.19) 0.467 1.17(0.70-2.03) 0.563
Jaundiced (vs no) 4.09(1.27-13.20) 0.011 2.56(0.70-9.44) 0.157
Creatinine per 1 mg/dl 1.37(1.27-1.48) < 0.001 1.33(1.23-1.45)* < 0.001
Urea per 30 mg/dl 1.29(1.22-1.37) < 0.001 1.24(1.17-1.32)* < 0.001
> 4 days of symptoms (vs ≤ 4 days) 0.96(0.62-1.51) 0.888 0.65(0.40-1.09) 0.106
* Because of multicollinearity urea and creatinine were not included together in the logistic model used to estimate the adjusted odds ratio for each of these two
variables. For the other adjusted odds ratios (i.e., for age, gender, jaundice, and duration of symptoms) both urea and creatinine were included in the logistic model.
Table 2
Dialysis, hemorrhagic events, death and duration of hospitalization by age groups
Pediatric Adult age groups All Adults
< 19 19-29 30-39 40-49 50-59 ≥ 60 ≥ 19 p among p (pediatric
n = 100 n = 213 n = 214 n = 145 n = 100 n = 68 n = 740 adults vs adults)
% death 3 5.6 10.3 21.4 28.0 36.8 15.9 <0.001 0.001
(3/100) (12/213) (22/214) (31/145) (28/100) (25/68) (118/740)
% death first 2 days 100 66.7 50.0 58.1 60.7 60.0 58.5 0.900 0.859
(3/3) (8/12) (11/22) (18/31) (17/28) (15/25) (69/118)
% dialyzed
total group 14.0 15.5 28.5 33.1 30.0 44.1 27.3 <0.001 0.004
(14/100) (33/213) (61/214) (48/145) (30/100) (30/68) (202/740)
survivors 13.4 12.9 22.9 21.9 19.4 27.9 19.5 0.053 0.155
(13/97) (26/201) (44/192) (25/114) (14/72) (12/43) (121/622)
% hemorrhagic events 20.0 24.4 25.2 25.5 25.0 14.7 24.1 0.455 0.370
(20/100) (52/213) (54/214) (37/145) (25/100) (10/68) (178/740)
Median length of
hospitalization (days)
total group 7 7 7 7 7 7 7 0.274 0.533
survivors 7 7 8 8 8 9 8 0.001 0.020
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p < 0.001). Jaundice was associated with death only in the unadjusted
analysis. Gender and duration of symptoms were not significantly
associated with death. The adjusted odds of death were almost four times
higher for adult than for pediatric patients (OR = 3.94, p = 0.029).
Figure 1 shows a more detailed picture of the adjusted association
between age and the odds of death by logistic regression. The odds of
death increased significantly with age (p for trend < 0.001). Compared
with the pediatric group, the adjusted odds of death were significantly
higher for all age groups ≥ 40. Among adults significant adjusted
differences in the odds of death were also observed between the age
group 19-29 and the age groups ≥ 40. Similar logistic regression adjusted
odds ratios were observed by using models restricted to icteric patients.
DISCUSSION
The case-fatality rate of leptospirosis was significantly lower for the
pediatric group than for the adult group. Moreover, among adults the
case-fatality rate of leptospirosis increased steadily from the younger to
the older groups. According to our data, among patients hospitalized
with leptospirosis approximately one out of 10 with ages 19 to 49 and
one out of four with ages above 49 years died from the disease. In addition
to a higher mortality risk, older patients were also more often treated by
dialysis both among those who survived and among those who died.
Among survivors, older patients had a longer median length of
hospitalization.
As consistently reported in studies among patients hospitalized with
leptospirosis there was a predominance of males. Despite the higher
mean age of females, a higher, but non-statistically significant, mortality
risk was observed for males. The direction of this association between
gender and risk of death, however, was inverted and remained statistically
non-significant after the logistic regression adjustment for the higher
average age of women. A similar observation was described by KO et
al. in a study also developed at Couto Maia Hospital10.
Higher prevalence of jaundice at hospital admission, and higher levels
of serum creatinine and urea were observed in older than in younger
patients. Because the distribution of serum creatinine in the general
population and in patients with renal diseases varies by age we used
different cut points for the serum creatinine. Both in the pediatric and
the adult groups, more than 90% of the patients had serum creatinine >
1.2 mg/dl at hospital admission. The differences by age were statistically
significant only for serum creatinine > 3.0 mg/dl. In a study developed
in São Paulo, Brazil, MAROTO et al. reported a frequency of 79% cases
of renal failure, defined as serum creatinine > 1.0 mg/dl, in 43 children
with leptospirosis, 4-14 years of age12. In our study a higher frequency
(94.1%) of patients with serum creatine > 1.0 mg/dl was observed among
34 children with ages ≤ 14 years. The frequency of serum creatinine
>  1.0 mg/dl was similar between ages ≤ 14 and 15-18 years. As observed
for age, levels of urea and creatinine and the presence of jaundice were
also significantly associated with higher risk of death. However, according
to our results, jaundice and degree of renal failure cannot fully explain
the strong association between age and case-fatality rate of leptospirosis.
In the present study the use of penicillin was not associated with
mortality risk and did not influence the association between age and the
odds of death in patients with leptospirosis. However, since our study
was retrospective, the results do not permit the conclusion that penicillin
is not beneficial for the patients that are hospitalized with leptospirosis.
Two previous retrospective studies have suggested that antimicrobial
therapy is beneficial for both children and adult with leptospirosis, by
reducing the extent of renal failure, thrombocytopenia or by shortening
the duration of illness9,12. Similar to our study, the results of those studies
do not permit to conclude that antimicrobial therapy reduce the risk of
death in patients hospitalized with leptospirosis. WATT et al., in a
randomized, double-blinded clinical trial among patients with
predominantly advanced leptospirosis, showed a smaller duration of
hospital stay and fever in patients treated with penicillin22. In this study
by WATT et al., however, it was not possible to assess the effect of
penicillin on the case-fatality rate because there was no death case, both
in the penicillin and the placebo groups. Results of our randomized
Fig. 1 - Logistic regression adjusted odds ratio of death by age group, using the pediatric
group (A) and the the age group 19-29 (B) as referent. The adjusted model included gender,
jaundice, creatinine (as continuous variable), urea (as continuous variable) and duration of
symptoms (> 4 days vs ≤ 4 days). The odds ratio after the addition of penicillin in the model
with the pediatric group as referent were: 1.5(p > 0.05), 2.6(p > 0.05), 5.8(p < 0.01), 8.0(p <
0.01) and 11.2(p < 0.01), for ages < 19-29, 30-39, 40-49, 50-59 and ≥ 60, respectively * p <
0.01. Odds ratios in a logistic model restricted to icteric patients, adjusted for creatinine, urea
and duration of symptoms, using the age group < 19 as referent were: 1.5 (p> 0.05), 2.5 (p >
0.05), 5.4(p < 0.01), 7.4(p < 0.01) and 11.3 (p < 0.01), for ages 19-29, 30-39, 40-49, 50-59
and ≥ 60, respectively.
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clinical trial in 253 leptospirosis patients 15 years of age or older, also
admitted to Couto Maia Hospital, suggest that the initiation of penicillin
after the fourth day of symptomatic disease is not associated with a
reduced risk of death. It has been shown, however, that the use of
antibiotics after high-risk exposure reduces the incidence of severe
leptospirosis8,16,20.
Because there were outbreaks of dengue during the period that the
patients were admitted to the hospital there was a concern that some
patients believed to have leptospirosis had in fact dengue and vice-
versa5,21. It should be noted, however, that diagnostic confusion with
dengue is likely to occur among patients with symptoms consistent with
less severe forms of leptospirosis, i.e., patients who are anicteric and do
not have renal failure. The majority of our patients were icteric or had
renal failure, findings that are consistent with the fact that the serogroup
icterohaemorrhagiae is the most frequently identified in patients admitted
to Couto Maia Hospital, where this study was developed1,10. Thus, during
the outbreaks of dengue fever the diagnosis of leptospirosis could be
delayed but misclassification of leptospirosis with dengue should be
seen as very unlikely in this sample, particularly among the icteric
patients. The fact that the age comparisons of mortality risk did not
change after restricting the analysis to icteric patients is an additional
piece of evidence that diagnostic misclassification should not have biased
our results toward a higher risk of death among adults as compared to
the pediatric patients. Missing data on death for patients transferred to
other hospitals should also not have biased the results, since whatever
were the outcome (i.e., death or survival), the trend to increase the case-
fatality rate with age would be present.
In conclusion, our data show evidence that pediatric patients have a
lower risk of death during hospitalization than adult patients with
leptospirosis. In addition, among adults, the mortality risk increased
steadily with age. Older patients were also more often treated by dialysis
and, among survivors, had longer length of hospitalization. Research is
still needed to identify the determinants of the high risk of death in
adults (as compared with pediatric patients) and older patients with
leptospirosis. We need also to identify which treatment interventions
may improve the prognosis of leptospirosis and reduce the gap in the
mortality risk between older and younger patients. The improvement in
the sanitary conditions of the urban cities in Brazil and the implementation
of other preventive measures should reduce the incidence of leptospirosis
and decrease the morbidity and mortality related to this disease.
RESUMO
Estudo comparativo da letalidade hospitalar da leptospirose entre
pacientes pediátricos e adultos de diferentes grupos etários
O objetivo principal foi comparar a letalidade hospitalar da
leptospirose entre pacientes pediátricos (< 19 anos) e adultos (≥ 19 anos),
levando em consideração gênero, função renal, duração dos sintomas e
icterícia. Prontuários de 1016 pacientes foram revistos. Análise
comparativa foi restrita a 840 pacientes (100 pediátricos, 740 adultos)
com informações sobre as variáveis incluídas na análise. Entre estes
pacientes 81,4% eram do sexo masculino e 91,5% apresentavam icterícia
à admissão. A letalidade da leptospirose foi 14,4%. A razão entre número
de pacientes que morreram e número de pacientes que sobreviveram,
ajustada para gênero, icterícia, duração de sintomas, uréia sérica e
creatinina sérica foi quase quatro vezes maior no grupo adulto do que
no pediátrico (odds ratio (OR) = 3,94; intervalo de confiança de 95% =
1,19-13,03, p = 0,029). Em adultos, idade mais avançada foi também
significantemente e independentemente associada com maior risco de
morte (p < 0,01). Pacientes mais velhos foram também mais
freqüentemente dialisados. Em conclusão, os dados mostram que a
letalidade da leptospirose é mais alta em adultos do que em crianças e
adolescentes, mesmo após o ajuste para os efeitos de potenciais fatores
de risco de morte. Entre adultos, idade avançada mostrou-se também
associada fortemente e independentemente com risco mais alto de
morte.
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